Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 1/2010

01.02.2010

Molecular Imaging of Thrombosis

verfasst von: Andrea J. Wiethoff, Marcus R. Makowski, Marcus Katoh, Elmar Spuentrup, René M. Botnar

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The diagnosis of thromboembolic diseases throughout the vascular system has been conducted with varying degrees of success by x-ray, ultrasound, CT, and MRI. Recently, a variety of potential molecular targets have been identified for early thrombus detection. This article describes these potential targets and the application of several imaging modalities currently being investigated to more accurately diagnose thrombosis and embolism.
Literatur
1.
Zurück zum Zitat Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995, 92:657–671.PubMed Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995, 92:657–671.PubMed
2.
Zurück zum Zitat Cutlip DE, Baim DS, Ho KK, et al.: Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001, 103:1967–1971.PubMed Cutlip DE, Baim DS, Ho KK, et al.: Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001, 103:1967–1971.PubMed
3.
Zurück zum Zitat Honda Y, Fitzgerald PJ: Stent thrombosis: an issue revisited in a changing world. Circulation 2003, 108:2–5.CrossRefPubMed Honda Y, Fitzgerald PJ: Stent thrombosis: an issue revisited in a changing world. Circulation 2003, 108:2–5.CrossRefPubMed
4.
Zurück zum Zitat Ojio S, Takatsu H, Tanaka T, et al.: Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000, 102:2063–2069.PubMed Ojio S, Takatsu H, Tanaka T, et al.: Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000, 102:2063–2069.PubMed
5.
Zurück zum Zitat Rittersma SZ, van der Wal AC, Koch KT, et al.: Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005, 111:1160–1165.CrossRefPubMed Rittersma SZ, van der Wal AC, Koch KT, et al.: Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005, 111:1160–1165.CrossRefPubMed
6.
Zurück zum Zitat Libby P: Act local, act global: inflammation and the multiplicity of “vulnerable” coronary plaques. J Am Coll Cardiol 2005, 45:1600–1602.CrossRefPubMed Libby P: Act local, act global: inflammation and the multiplicity of “vulnerable” coronary plaques. J Am Coll Cardiol 2005, 45:1600–1602.CrossRefPubMed
7.
Zurück zum Zitat Casscells W, Naghavi M, Willerson, JT: Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003, 107:2072–2075.CrossRefPubMed Casscells W, Naghavi M, Willerson, JT: Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003, 107:2072–2075.CrossRefPubMed
8.
Zurück zum Zitat Gardner C, Lee K: Embolic stroke: classification, risk factors, and clinical pearls. Applied Neurology 2006, 2:7. Gardner C, Lee K: Embolic stroke: classification, risk factors, and clinical pearls. Applied Neurology 2006, 2:7.
9.
Zurück zum Zitat Kronzon I, Tunick PA: Aortic atherosclerotic disease and stroke. Circulation 2006, 114:63–75.CrossRefPubMed Kronzon I, Tunick PA: Aortic atherosclerotic disease and stroke. Circulation 2006, 114:63–75.CrossRefPubMed
10.
Zurück zum Zitat Merli GJ: The treatment of venous thromboembolism. Am J Med 2008, 121. Merli GJ: The treatment of venous thromboembolism. Am J Med 2008, 121.
12.
Zurück zum Zitat Olin JW: Pulmonary embolism. Rev Cardiovasc Med 2002, 3:S68–S75.PubMed Olin JW: Pulmonary embolism. Rev Cardiovasc Med 2002, 3:S68–S75.PubMed
13.
Zurück zum Zitat Pengo V, Lensing AW, Prins MH, et al.: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004, 350:2257–2264.CrossRefPubMed Pengo V, Lensing AW, Prins MH, et al.: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004, 350:2257–2264.CrossRefPubMed
14.
Zurück zum Zitat Williamson TL, Kim NH, Rubin LJ: Chronic thromboembolic pulmonary hypertension. Prog Cardiovasc Dis 2002, 45:203–212.CrossRefPubMed Williamson TL, Kim NH, Rubin LJ: Chronic thromboembolic pulmonary hypertension. Prog Cardiovasc Dis 2002, 45:203–212.CrossRefPubMed
15.
Zurück zum Zitat Jamieson SW, Kapelanski DP, Sakakibara N, et al.: Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003, 76:1457–1462; discussion 1462–1464. Jamieson SW, Kapelanski DP, Sakakibara N, et al.: Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003, 76:1457–1462; discussion 1462–1464.
16.
Zurück zum Zitat Sorensen HT, Horvath-Puho E, Pedersen L, et al.: Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007, 370:773–779. Sorensen HT, Horvath-Puho E, Pedersen L, et al.: Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007, 370:773–779.
17.
Zurück zum Zitat Towbin A: The syndrome of latent cerebral sinus venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke 1973, 4:419–430.PubMed Towbin A: The syndrome of latent cerebral sinus venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke 1973, 4:419–430.PubMed
18.
Zurück zum Zitat Botnar RM, Perez AS, Witte S, et al.: In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004, 109: 2023–2029.CrossRefPubMed Botnar RM, Perez AS, Witte S, et al.: In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004, 109: 2023–2029.CrossRefPubMed
19.
Zurück zum Zitat Botnar RM, Buecker A, Wiethoff AJ, et al.: In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004, 110:1463–1466.CrossRefPubMed Botnar RM, Buecker A, Wiethoff AJ, et al.: In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004, 110:1463–1466.CrossRefPubMed
20.
Zurück zum Zitat Yu X, Song SK, Chen J, et al.: High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000, 44:867–872.CrossRefPubMed Yu X, Song SK, Chen J, et al.: High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000, 44:867–872.CrossRefPubMed
21.
Zurück zum Zitat Flacke S, Fischer S, Scott MJ, et al.: Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001, 104:1280–1285.CrossRefPubMed Flacke S, Fischer S, Scott MJ, et al.: Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001, 104:1280–1285.CrossRefPubMed
22.
Zurück zum Zitat Spuentrup E, Buecker A, Katoh M, et al.: Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005, 111:1377–1482.CrossRefPubMed Spuentrup E, Buecker A, Katoh M, et al.: Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005, 111:1377–1482.CrossRefPubMed
23.
Zurück zum Zitat Tung CH, Gerszten RE, Jaffer FA, et al.: A novel near-infrared fluorescence sensor for detection of thrombin activation in blood. Chembiochem 2002, 3:207–211.CrossRefPubMed Tung CH, Gerszten RE, Jaffer FA, et al.: A novel near-infrared fluorescence sensor for detection of thrombin activation in blood. Chembiochem 2002, 3:207–211.CrossRefPubMed
24.
Zurück zum Zitat Jaffer FA, Tung CH, Wykrzykowska JJ, et al.: Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 2004, 110:170–176.CrossRefPubMed Jaffer FA, Tung CH, Wykrzykowska JJ, et al.: Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 2004, 110:170–176.CrossRefPubMed
25.
Zurück zum Zitat Tung CH, Quinti L, Jaffer FA, et al.: A branched fluorescent peptide probe for imaging of activated platelets. Mol Pharm 2005, 2:92–95.CrossRefPubMed Tung CH, Quinti L, Jaffer FA, et al.: A branched fluorescent peptide probe for imaging of activated platelets. Mol Pharm 2005, 2:92–95.CrossRefPubMed
26.
Zurück zum Zitat Bates SM, Lister-James J, Jullian JA, et al.: Imaging characteristics of a novel technetium Tc-99m labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients with acute deep vein thrombosis or a history of deep vein thrombosis. Arch Intern Med 2003, 163:452–456.CrossRefPubMed Bates SM, Lister-James J, Jullian JA, et al.: Imaging characteristics of a novel technetium Tc-99m labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients with acute deep vein thrombosis or a history of deep vein thrombosis. Arch Intern Med 2003, 163:452–456.CrossRefPubMed
27.
Zurück zum Zitat Morris TA, Marsh JJ, Chiles PG, et al.: Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer. Am J Respir Crit Care Med 2004, 169:987–993.CrossRefPubMed Morris TA, Marsh JJ, Chiles PG, et al.: Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer. Am J Respir Crit Care Med 2004, 169:987–993.CrossRefPubMed
28.
Zurück zum Zitat Sarda-Mantel L, Coutard M, Rouzet F, et al.: 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26:2153–2159.CrossRefPubMed Sarda-Mantel L, Coutard M, Rouzet F, et al.: 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26:2153–2159.CrossRefPubMed
29.
Zurück zum Zitat Lanza GM, Wallace KD, Scott MJ, et al.: A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996, 94:3334–3340.PubMed Lanza GM, Wallace KD, Scott MJ, et al.: A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996, 94:3334–3340.PubMed
30.
Zurück zum Zitat Schumann PA, Christiansen JP, Quigley RM, et al.: Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 2002, 37:587–593.CrossRefPubMed Schumann PA, Christiansen JP, Quigley RM, et al.: Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 2002, 37:587–593.CrossRefPubMed
31.
Zurück zum Zitat Alonso A, Della Martina A, Stroick M, et al.: Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 2007, 38:508–514.CrossRef Alonso A, Della Martina A, Stroick M, et al.: Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 2007, 38:508–514.CrossRef
32.
Zurück zum Zitat Lindener JR: Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009, 6:475–481.CrossRef Lindener JR: Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009, 6:475–481.CrossRef
33.
Zurück zum Zitat Jaffer FA, Tung CH, Gerszten RE, et al.: In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol 2002, 22:1929–1935.CrossRefPubMed Jaffer FA, Tung CH, Gerszten RE, et al.: In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol 2002, 22:1929–1935.CrossRefPubMed
34.
Zurück zum Zitat Kim DE, Jaffer FA, Weissleder R, et al.: Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab 2005, 25:226–233.CrossRefPubMed Kim DE, Jaffer FA, Weissleder R, et al.: Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab 2005, 25:226–233.CrossRefPubMed
35.
Zurück zum Zitat • Jaffer FA, Libby P, Weissleder R: Molecular imaging of cardiovascular disease. Circulation 2007, 116:1052–1061. This is a comprehensive review of the recent state of cardiovascular molecular imaging. • Jaffer FA, Libby P, Weissleder R: Molecular imaging of cardiovascular disease. Circulation 2007, 116:1052–1061. This is a comprehensive review of the recent state of cardiovascular molecular imaging.
36.
Zurück zum Zitat Moody AR, Murphy RE, Morgan PS, et al.: Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003, 107:3047–3052.CrossRefPubMed Moody AR, Murphy RE, Morgan PS, et al.: Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003, 107:3047–3052.CrossRefPubMed
37.
Zurück zum Zitat Murphy RE, Moody AR, Morgan PS, et al.: Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 2003, 107:3053–3058.CrossRefPubMed Murphy RE, Moody AR, Morgan PS, et al.: Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 2003, 107:3053–3058.CrossRefPubMed
38.
Zurück zum Zitat Moody AR: Direct imaging of deep-vein thrombosis with magnetic resonance imaging. Lancet 1997, 350:1073. Moody AR: Direct imaging of deep-vein thrombosis with magnetic resonance imaging. Lancet 1997, 350:1073.
39.
Zurück zum Zitat van Beek EJ, Wild JM, Fink C, et al.: MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 2003, 18:627–640.CrossRefPubMed van Beek EJ, Wild JM, Fink C, et al.: MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 2003, 18:627–640.CrossRefPubMed
40.
Zurück zum Zitat Winter PM, Caruthers SD, Yu X, et al.: Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003, 50:411–416.CrossRefPubMed Winter PM, Caruthers SD, Yu X, et al.: Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003, 50:411–416.CrossRefPubMed
41.
Zurück zum Zitat Morawski AM, Winter PM, Yu X, et al.: Quantitative “magnetic resonance immunohistochemistry” with ligand-targeted 19F nanoparticles. Magn Reson Med 2004, 52:1255–1262.CrossRefPubMed Morawski AM, Winter PM, Yu X, et al.: Quantitative “magnetic resonance immunohistochemistry” with ligand-targeted 19F nanoparticles. Magn Reson Med 2004, 52:1255–1262.CrossRefPubMed
42.
Zurück zum Zitat McCarthy JR, Patel P, Botnaru I, et al.: Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug Chem 2009, 20:1251–1255.CrossRefPubMed McCarthy JR, Patel P, Botnaru I, et al.: Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug Chem 2009, 20:1251–1255.CrossRefPubMed
43.
Zurück zum Zitat Spuentrup E, Fausten B, Kinzel S, et al.: Molecular MR-imaging of atrial clots in a swine model. Circulation 2005, 112:396–399.CrossRefPubMed Spuentrup E, Fausten B, Kinzel S, et al.: Molecular MR-imaging of atrial clots in a swine model. Circulation 2005, 112:396–399.CrossRefPubMed
44.
Zurück zum Zitat Stracke CP, Katoh M, Wiethoff AJ, et al.: Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent. Stroke 2007, 38:1476–1481.CrossRefPubMed Stracke CP, Katoh M, Wiethoff AJ, et al.: Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent. Stroke 2007, 38:1476–1481.CrossRefPubMed
45.
Zurück zum Zitat Sirol M, Fuster V, Badimon JJ, et al.: Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005, 112:1594–1600.CrossRefPubMed Sirol M, Fuster V, Badimon JJ, et al.: Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005, 112:1594–1600.CrossRefPubMed
46.
Zurück zum Zitat Spuentrup E, Katoh M, Wiethoff AJ, et al.: Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model. Rofo 2007, 179:1166–1173.PubMed Spuentrup E, Katoh M, Wiethoff AJ, et al.: Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model. Rofo 2007, 179:1166–1173.PubMed
47.
Zurück zum Zitat Spuentrup E, Katoh M, Buecker A, et al.: Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent. Invest Radiol 2007, 42:86–95.CrossRef Spuentrup E, Katoh M, Buecker A, et al.: Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent. Invest Radiol 2007, 42:86–95.CrossRef
48.
Zurück zum Zitat •• Vymazal J, Spuentrup E, Cardenas-Molina G, et al.: Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol 2009, 44:697–704. This article reports the feasibility of the first molecularly targeted Gd MRI agent in humans. •• Vymazal J, Spuentrup E, Cardenas-Molina G, et al.: Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol 2009, 44:697–704. This article reports the feasibility of the first molecularly targeted Gd MRI agent in humans.
49.
Zurück zum Zitat Spuentrup E, Botnar RM, Wiethoff AJ, et al.: MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 2008, 18:1995–2005.CrossRefPubMed Spuentrup E, Botnar RM, Wiethoff AJ, et al.: MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 2008, 18:1995–2005.CrossRefPubMed
50.
Zurück zum Zitat Johansson LO, Bjørnerud A, Ahlström HK, et al.: A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution. J Magn Reson Imaging 2001, 13:615–618.CrossRefPubMed Johansson LO, Bjørnerud A, Ahlström HK, et al.: A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution. J Magn Reson Imaging 2001, 13:615–618.CrossRefPubMed
Metadaten
Titel
Molecular Imaging of Thrombosis
verfasst von
Andrea J. Wiethoff
Marcus R. Makowski
Marcus Katoh
Elmar Spuentrup
René M. Botnar
Publikationsdatum
01.02.2010
Verlag
Current Science Inc.
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 1/2010
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-009-9005-0

Weitere Artikel der Ausgabe 1/2010

Current Cardiovascular Imaging Reports 1/2010 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.